Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Report – Research, Industry Analysis Reports and Market Demands

Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Base Type
- 1.3.3 Chemically Modified Type
1.4 Market Analysis by Formulations
- 1.4.1 Overview: Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Formulations: 2021 Versus 2025 Versus 2032
- 1.4.2 Injectable
- 1.4.3 Oral Preparations
- 1.4.4 Other
1.5 Market Analysis by Application
- 1.5.1 Overview: Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Solubilizer
- 1.5.3 Emulsifier
- 1.5.4 Excipient
- 1.5.5 Others
1.6 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size & Forecast
- 1.6.1 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity (2021-2032)
- 1.6.3 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Pharmaceutical Grade HCO (Hydrogenated Castor Oil) by Manufacturer

3.1 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Manufacturer (2021-2026)
3.2 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Revenue by Manufacturer (2021-2026)
3.3 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Pharmaceutical Grade HCO (Hydrogenated Castor Oil) by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Manufacturer Market Share in 2025
- 3.4.3 Top 6 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Manufacturer Market Share in 2025
3.5 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market: Overall Company Footprint Analysis
- 3.5.1 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market: Region Footprint
- 3.5.2 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market: Company Product Type Footprint
- 3.5.3 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size by Region
- 4.1.1 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Region (2021-2032)
- 4.1.2 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Region (2021-2032)
- 4.1.3 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Average Price by Region (2021-2032)
4.2 North America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value (2021-2032)
4.3 Europe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value (2021-2032)
4.4 Asia-Pacific Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value (2021-2032)
4.5 South America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value (2021-2032)
4.6 Middle East & Africa Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Type (2021-2032)
5.2 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Type (2021-2032)
5.3 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Application (2021-2032)
6.2 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Application (2021-2032)
6.3 Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Average Price by Application (2021-2032)

7 North America

7.1 North America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Type (2021-2032)
7.2 North America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Application (2021-2032)
7.3 North America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size by Country
- 7.3.1 North America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Country (2021-2032)
- 7.3.2 North America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Type (2021-2032)
8.2 Europe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Application (2021-2032)
8.3 Europe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size by Country
- 8.3.1 Europe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size by Region
- 9.3.1 Asia-Pacific Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Type (2021-2032)
10.2 South America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Application (2021-2032)
10.3 South America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size by Country
- 10.3.1 South America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Country (2021-2032)
- 10.3.2 South America Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Size by Country
- 11.3.1 Middle East & Africa Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Drivers
12.2 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market Restraints
12.3 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Pharmaceutical Grade HCO (Hydrogenated Castor Oil) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Grade HCO (Hydrogenated Castor Oil)
13.3 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Typical Distributors
14.3 Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size was valued at US$ 2225 million in 2025 and is forecast to a readjusted size of US$ 3314 million by 2032 with a CAGR of 6.2% during review period.
Pharmaceutical grade HCO (hydrogenated castor oil) is a high-purity excipient derived from the catalytic hydrogenation of refined castor oil, primarily consisting of glycerol tris(12-hydroxystearate). It is produced under stringent GMP standards and is characterized by its superior chemical stability and hydrophobic properties, making it an essential lubricant, stiffening agent, or matrix-former for controlled-release systems. This report primarily focuses on pharmaceutical-grade HCO and its derivatives, such as Polyoxyl Hydrogenated Castor Oils (e.g., PEG-40 Hydrogenated Castor Oil), which are widely utilized as potent solubilizers and emulsifiers in liquid formulations. Compared to industrial grades, pharmaceutical-grade HCO and its derivatives must adhere to rigorous pharmacopoeia standards (such as USP, EP, or ChP), ensuring strict control over acid values, impurity profiles, and biocompatibility for patient safety. in 2025, global pharmaceutical grade HCO sales volume was 925,000 tons, with an average unit price of US$2,445 per ton and a gross profit margin ranging from 25% to 45%. The global pharmaceutical-grade HCO industry chain is based on upstream castor seed cultivation and castor oil production. Raw materials are mainly concentrated in regions rich in castor resources such as India, China, and Brazil. After hydrogenation, refining, and pharmaceutical-grade quality control, intermediate products are formed. In the midstream, fine chemical and pharmaceutical excipient companies with GMP systems complete deep processing, focusing on controlling impurities, peroxide value, and batch stability. Downstream, it is mainly used in the pharmaceutical field as a nonionic surfactant, solubilizer, and emulsifier, widely used in injections, oral liquids, soft capsules, and topical preparations. It also extends to medical nutritional preparations and some high-end medical device-related formulations. The overall demand is highly correlated with the global trend of generic drugs, biological agents, and premium formulations.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade HCO (Hydrogenated Castor Oil)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, Croda, Kao, Nikkol Group, Itoh OilChem, Nihon Emulsion, Corel Pharma Chem, Shanxi Dideu Medichem, Jayant Agro-Organics, Inner Mongolia Weiyu Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Base Type
Chemically Modified Type
Market segment by Formulations
Injectable
Oral Preparations
Other
Market segment by Application
Solubilizer
Emulsifier
Excipient
Others
Major players covered
BASF
Croda
Kao
Nikkol Group
Itoh OilChem
Nihon Emulsion
Corel Pharma Chem
Shanxi Dideu Medichem
Jayant Agro-Organics
Inner Mongolia Weiyu Biotech
Shanghai Better Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade HCO (Hydrogenated Castor Oil), with price, sales quantity, revenue, and global market share of Pharmaceutical Grade HCO (Hydrogenated Castor Oil) from 2021 to 2026.
Chapter 3, the Pharmaceutical Grade HCO (Hydrogenated Castor Oil) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade HCO (Hydrogenated Castor Oil) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade HCO (Hydrogenated Castor Oil).
Chapter 14 and 15, to describe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) sales channel, distributors, customers, research findings and conclusion.

Buy now